Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 15.6B | 16.7B | 16.3B | 15.8B |
Cost of revenue | 10.2B | 10.5B | 10.2B | 10.5B |
Gross profit | 5.4B | 6.2B | 6.0B | 5.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 915.4M | 930.8M | 936.1M | 920.7M |
Other operating expenses | 1.2B | 1.3B | 1.3B | 1.2B |
Operating income | 3.3B | 4.0B | 3.8B | 3.2B |
Non operating interest income | ||||
Income | 284.8M | 292.5M | 297.5M | 288.3M |
Expense | 431.2M | 430.3M | 398.1M | 435.6M |
Other income expense | 100.9M | 6.7M | -172.0M | 65.4M |
Pretax income | 3.2B | 3.8B | 3.5B | 3.1B |
Tax provision | 467.7M | 555.2M | 430.8M | 430.8M |
Net income | 2.8B | 3.3B | 3.1B | 2.7B |
Basic EPS | 3.6 | 4.3 | 4.0 | 3.5 |
Diluted EPS | 3.6 | 4.3 | 4.0 | 3.5 |
Basic average shares | 763.9M | 764.7M | 771.4M | 772.8M |
Diluted average shares | 763.9M | 764.7M | 771.4M | 772.8M |
EBITDA | 3.7B | 4.3B | 4.1B | 3.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |